MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Genedrive completes assay design for Covid-19 test kit

StockMarketWire.com

Diagnostics company Genedrive said it had completed the assay design of its COVID-19 testing and was now generating 'very promising' analytical data aligned to market requirements.

The company's SARS-CoV-2 POC Kit was being designed to detect the Covid-19 virus in saliva without the need to extract viral RNA.

'This expanded the potential use areas of the product and importantly, allows for rapid testing to be performed while a patient was present,' the company said.





At 8:32am: (LON:GDR) Genedrive Plc share price was -4.5p at 108.5p



Story provided by StockMarketWire.com